Marmoset CYP3A21, a model for human CYP3A4: Protein expression and functional characterization of the promoter

References

• Asif AR, Oellerich M, Armstrong VW, Riemenschneider B, Monod M, Reichard U. Proteome of conidial surface associated proteins of Aspergillus fumigatus reflecting potential vaccine candidates and allergens. Journal of Proteome Research 2006; 5: 954–962
   PubMed Web of Science ®Google Scholar
• Bertilsson G, Berkenstam A, Blomquist P. Functionally conserved xenobiotic responsive enhancer in Cytochrome P450 3A7. Biochemical and Biophysical Research Communications 2001; 280: 139–144
   PubMed Web of Science ®Google Scholar
• Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L, Sydow-Bäckman M, Ohlsson R, Postlind H, Blomquist P, Berkenstam A. Identification of a human nuclear receptor defines a new signaling pathway for Cyp3A induction. Proceedings of the National Academy of Sciences USA 95. 1998; 12208–12213
   Google Scholar
• Blumberg B, Sabbagh W, Jr, Huguilon H, Bolado J, Jr, Van Meter CM, Ong ES, Evans RM. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes and Development 1998; 12: 3195–3205
   PubMed Web of Science ®Google Scholar
• Burk O, Wojnowski L. Cytochrome P450 3A and their regulation. Naunyn-Schmiedeberg's Archives of Pharmacology 2004; 369: 105–124
   PubMed Web of Science ®Google Scholar
• Burk O, Koch I, Raucy J, Hustert E, Eichelbaum M, Brockmöller J, Zanger UM, Wojnowski L. The induction of Cytochrome P450 3A5 (Cyp3A5) in the human liver and intestine is mediated by the xenobiotic sensors Pregnane X Receptor (PXR) and Constitutively Activated Receptor (CAR). Journal of Biological Chemistry 2004; 279: 38379–38385
   PubMed Web of Science ®Google Scholar
• Burk O, Tegude H, Koch I, Hustert E, Wolbold R, Glaeser H, Klein K, Fromm MF, Nuessler AK, Neuhaus P, Zanger UM, Eichelbaum M, Wojnowski L. Molecular mechanisms of polymorphic Cyp3A7 expression in adult human liver and intestine. Journal of Biological Chemistry 2002; 277: 24280–24288
   PubMed Web of Science ®Google Scholar
• Cholerton S, Daly AK, Idle JR. The role of individual human cytochromes P450 in drug metabolism and clinical response. Trends in Pharmacological Sciences 1992; 12: 434–439
   Google Scholar
• Goodwin B, Hodgson E, D’Costa DJ, Robertson GR, Liddle C. Transcriptional regulation of the human CYP3A4 gene by the Constitutive Androstane Receptor. Molecular Pharmacology 2002; 62: 359–365
   PubMed Web of Science ®Google Scholar
• Goodwin B, Hodgson E, Liddle C. The orphan human pregnane X receptor mediates the transcriptional activation of Cyp3A4 by rifampicin through a distal enhancer module. Molecular Pharmacology 1999; 56: 1329–1339
   PubMed Web of Science ®Google Scholar
• Hashimoto H, Toide K, Kitamura R, Fujita M, Tagawa S, Itoh S, Kamataki T. Gene structure of Cyp3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control. European Journal of Biochemistry 1993; 218: 585–595
   PubMedGoogle Scholar
• Huss JM, Kasper CB. Nuclear receptor involvement in the regulation of rat Cytochrome P450 3A23 expression. Journal of Biological Chemistry 1998; 273: 16155–16162
   PubMed Web of Science ®Google Scholar
• Hustert E, Zibat A, Presecan-Siedel. E, Eiselt R, Mueller R, Fuß C, Brehm I, Brinkmann U, Eichelbaum M, Wojnowski L, Burk O. Natural protein variants of Pregnane X Receptor with altered transactivation activity toward Cyp3A4. Drug Metabolism and Disposition 2001; 29: 1454–1459
   PubMed Web of Science ®Google Scholar
• Igarashi T, Sakuma T, Isogai M, Nagata R, Kamataki T. Marmoset liver cytochrome P450s: Study for expression and molecular cloning of their cDNAs. Archives of Biochemistry and Biophysics 1997; 339: 85–91
   PubMed Web of Science ®Google Scholar
• Kel AE, Gößling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, Wingender E. MATCHTM: A tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Research 2003; 31: 3576–3579
   PubMed Web of Science ®Google Scholar
• Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. The Human Genome Browser at UCSC. Genome Research 2002; 12: 996–1006
   PubMed Web of Science ®Google Scholar
• Kocarek TA, Schuetz EG, Strom SC, Fisher RA, Guzelian PS. Comparative analysis of cytochrome P450 3A induction in primary cultures of rat, rabbit, and human hepatocytes. Drug Metabolism and Disposition 1995; 23: 415–421
   PubMed Web of Science ®Google Scholar
• Leakey JEA, Althaus ZR, Bailey JR. Dexamethasone induces hepatic cytochrome P-450 content and increases certain monooxygenase activities in rhesus monkey fetuses. Biochemical Pharmacology 1986; 35: 1389–1391
   PubMed Web of Science ®Google Scholar
• Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA. The human orphan nuclear receptor PXR is activated by compounds that regulate Cyp3A4 gene expression and cause drug interactions. Journal of Clinical Investigation 1998; 102: 1016–1023
   PubMed Web of Science ®Google Scholar
• Li AP, Kaminski DL, Rasmussen A. Substrates of human hepatic cytochrome P450 3A4. Toxicology 1995; 104: 1–8
   PubMed Web of Science ®Google Scholar
• Martínez-Jiménez CP, Gómez-Lechón MJ, Castell JV, Jover R. Transcriptional regulation of the human hepatic Cyp3A4: Identification of a new distal enhancer region responsive to CCAAT/enhancer-binding protein beta isoforms (liver activating protein and liver inhibitory protein). Molecular Pharmacology 2005; 67: 2088–2101
   PubMed Web of Science ®Google Scholar
• McArthur AG, Hegelund T, Cox RL, Stegeman JJ, Liljenberg M, Olsson U, Sundberg P, Celander MC. Phylogenetic analysis of the cytochrome P450 3 (CYP3) gene family. Journal of Molecular Evolution 2003; 57: 200–211
   PubMed Web of Science ®Google Scholar
• Nelson DR, Zeldin DC, Hoffman SM. G, Maltais LJ, Wain HM, Nebert DW. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 2004; 14: 1–18
   PubMedGoogle Scholar
• Pascussi J-M, Drocourt L, Gerbal-Chaloin S, Fabre J-M, Maurel P, Vilarem M-J. Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. European Journal of Biochemistry 2001; 268: 6346–6358
   PubMedGoogle Scholar
• Robertson GR, Field J, Goodwin B, Bierach S, Tran M, Lehnert A, Liddle C. Transgenic mouse models of human Cyp3A4 gene regulation. Molecular Pharmacology 2003; 64: 42–50
   PubMed Web of Science ®Google Scholar
• Schulz T. Zur Eignung von Primaten als Tiermodell in der Toxikologie unter besonderer Berücksichtigung der polyhalogenierten Dibenzodioxine. Habilitationsschrift Cuvillier Verlag Göttingen. 2000
   Google Scholar
• Shu Y, Cheng Z-N, Liu Z-Q, Wang L-S, Zhu B, Huang S-L, Ou-Yang DS, Zhou H-H. Interindividual variations in levels and activities of cytochrome P-450 in liver microsomes of Chinese subjects. Acta Pharmacologica Sinica 2001; 22: 283–288
   PubMed Web of Science ®Google Scholar
• Sy SKB, Ciaccia A, Li W, Roberts EA, Okey A, Kalow W, Tang B-K. Modeling of human hepatic Cyp 3A4 enzyme kinetics, protein, and mRNA indicates deviation from log-normal distribution in Cyp3A4 gene expression. European Journal of Clinical Pharmacology 2002; 58: 357–365
   PubMedGoogle Scholar
• Takada T, Ogino M, Miyata M, Shimada M. Differences in transactivation between rat CYP3A1 and human CYP3A4 genes by human pregnane X receptor. Drug Metabolism and Pharmacokinetics 2004; 19: 103–113
   PubMedGoogle Scholar
• Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, Ishizuka H, Kharasch E, Schuetz J, Schuetz E. Transcriptional control of intestinal Cytochrome P-4503A by 1a,25-dihydroxy vitamin D3. Molecular Pharmacology 2001; 60: 1399–1406
   PubMed Web of Science ®Google Scholar
• Tom BH, Rutzky LP, Jakstys MM, Oyasu R, Kaye CI, Kahan BD. Human colonic adenocarcinoma cells. I. Establishment and description of a new line. In vitro 1976; 12: 180–191
   Google Scholar
• Watanabe M, Kumai T, Matsumoto N, Tanaka M, Suzuki S, Satoh T, Kobayashi S. Expression of CYP3A4 mRNA is correlated with CYP3A4 protein level and metabolic activity in human liver. Journal of Pharmacological Sciences 2004; 94: 459–462
   PubMed Web of Science ®Google Scholar
• Westlind-Johnsson A, Malmebo S, Johansson A, Otter C, Andersson TB, Johansson I, Edwards RJ, Boobis AR, Ingelman-Sundberg M. Comparative analysis of Cyp3A expression in human liver suggests only a minor role for Cyp3A5 in drug metabolism. Drug Metabolism and Disposition 2003; 31: 755–761
   PubMed Web of Science ®Google Scholar
• Williams ET, Rodin AS, Strobel HW. Defining relationships between the known members of the cytochrome P450 3A subfamily, including five putative chimpanzee members. Molecular Phylogenetics and Evolution 2004; 33: 300–308
   PubMed Web of Science ®Google Scholar
• Wojnowski L. Genetics of the variable expression of Cyp3A in humans. Therapeutic Drug Monitoring 2004; 26: 192–199
   PubMed Web of Science ®Google Scholar